Literature DB >> 11299830

C-myc amplification and cluster analysis in human gastric carcinoma.

L Kozma1, I Kiss, J Hajdú, Z Szentkereszty, S Szakáll, I Ember.   

Abstract

The tumour samples ot 23 patients (9 male, 14 female, aged 28-85) were randomly selected for the study. DNA was isolated from paraffin embedded tissue for quantitative dot-blot hybridization, in order to determine the amplification values for the c-myc and K-ras oncogenes. The clinical and histological parameters studied were as follows: grade, TNM staging system, Lauren's histological type, localization and the severity of the disease. Amplified c-myc was found in 6 cases. Amplification was concomitant with c-myc overexpression detected with immunohistochemical staining. The amplification--9.1-fold on the average (ranging from 2.12 to 18.2) was significantly associated with the presence of distant metastasis (corr. coeff.: 0.5623, p < 0.01), but with none of the other parameters. No case with K-ras amplification was recorded. The result of the multivariate cluster analysis proved that age was the decisive factor in the segregation process. This age-related distribution (69 vs. 40, p < 0.001), however, did not coincide with either the incidence of distant metastasis or c-myc amplification.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11299830

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  8 in total

1.  The impact of C-MYC gene expression on gastric cancer cell.

Authors:  Lin Zhang; Yanhong Hou; Hassan Ashktorab; Liucun Gao; Yanjie Xu; Kai Wu; Junshan Zhai; Lei Zhang
Journal:  Mol Cell Biochem       Date:  2010-08-25       Impact factor: 3.396

2.  Clinical implication of 14-3-3 epsilon expression in gastric cancer.

Authors:  Mariana Ferreira Leal; Danielle Queiroz Calcagno; Sâmia Demachki; Paulo Pimentel Assumpção; Roger Chammas; Rommel Rodríguez Burbano; Marília de Arruda Cardoso Smith
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

3.  The influence of TXNDC5 gene on gastric cancer cell.

Authors:  Lin Zhang; Yanhong Hou; Nan Li; Kai Wu; Junshan Zhai
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-16       Impact factor: 4.553

Review 4.  CXC chemokines and chemokine receptors in gastric cancer: from basic findings towards therapeutic targeting.

Authors:  Hyo Jin Lee; Ik-Chan Song; Hwan-Jung Yun; Deog-Yeon Jo; Samyong Kim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

5.  Loss of fragile histidine triad and amplification of 1p36.22 and 11p15.5 in primary gastric adenocarcinomas.

Authors:  Yuan-Yuan Liu; Hai-Ying Chen; Man-Li Zhang; Dan Tian; Shibo Li; Ji-Yun Lee
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 6.  MYC and gastric adenocarcinoma carcinogenesis.

Authors:  Danielle-Queiroz Calcagno; Mariana-Ferreira Leal; Paulo-Pimentel Assumpcao; Marilia-Arruda-Cardoso Smith; Rommel-Rodriguez Burbano
Journal:  World J Gastroenterol       Date:  2008-10-21       Impact factor: 5.742

7.  Profiling age-related epigenetic markers of stomach adenocarcinoma in young and old subjects.

Authors:  Byoung-Chul Kim; Hyoung Oh Jeong; Daeui Park; Chul-Hong Kim; Eun Kyeong Lee; Dae Hyun Kim; Eunok Im; Nam Deuk Kim; Sunghoon Lee; Byung Pal Yu; Jong Bhak; Hae Young Chung
Journal:  Cancer Inform       Date:  2015-04-20

8.  The diagnostic value of serum gastrokine 1 (GKN1) protein in gastric cancer.

Authors:  Jung Hwan Yoon; Yong Gyu Park; Suk Woo Nam; Won Sang Park
Journal:  Cancer Med       Date:  2019-08-03       Impact factor: 4.452

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.